Literature DB >> 23965768

Sexually transmitted infection prevalence in a population seeking no-cost contraception.

Colleen McNicholas1, Jeffrey F Peipert, Ragini Maddipati, Tessa Madden, Jenifer E Allsworth, Gina M Secura.   

Abstract

BACKGROUND: We used universal screening to determine the prevalence rates of Neisseria gonorrhoeae (GC), Chlamydia trachomatis (CT), and Trichomonas vaginalis (TV) in 9256 women enrolling into a contraceptive study.
METHODS: We offered screening using nucleic acid amplification or culture to all participants enrolling into the Contraceptive CHOICE Project. Demographic characteristics were collected through staff-administered questionnaires. Univariate and multivariable analyses were performed to assess the risk of sexually transmitted infection at baseline and to compare risk profiles of CT and TV.
RESULTS: Results were available for 8347 consenting women with satisfactory results; 656 (7.9%) were tested positive for 1 or more infections. Approximately one third of participants were older than 26 years, and half were identified as African American. There were 35 cases of GC for a prevalence of 0.4% (95% confidence interval [CI], 0.3-0.6), 260 cases of CT for a prevalence of 3.1% (95% CI, 2.8-3.5), and 410 cases of TV for a prevalence of 4.9% (95% CI, 4.4-5.4). Black women were more likely to be tested positive (odds ratio, 3.95; 95% CI, 3.08-5.06) compared with white women and accounted for 81.3% of cases. T. vaginalis was more prevalent in black women (8.9%) compared with white women (0.9%). Older age was a risk factor for TV, whereas younger age was associated with CT. Of the 656 positive cases, 106 (16%) were diagnosed in women older than 25 years, falling outside traditional screening guidelines.
CONCLUSION: We found GC, CT, and TV to be more prevalent than current national statistics, with TV being the most prevalent. Current screening recommendations would have missed 16% of infected women.

Entities:  

Mesh:

Year:  2013        PMID: 23965768      PMCID: PMC3752093          DOI: 10.1097/OLQ.0b013e31829529eb

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  19 in total

1.  Effect of acute pelvic inflammatory disease on fertility.

Authors:  L Weström
Journal:  Am J Obstet Gynecol       Date:  1975-03-01       Impact factor: 8.661

Review 2.  Clinical practice. Genital chlamydial infections.

Authors:  Jeffrey F Peipert
Journal:  N Engl J Med       Date:  2003-12-18       Impact factor: 91.245

3.  The association between Chlamydia trachomatis and ectopic pregnancy. A matched-pair, case-control study.

Authors:  J M Chow; M L Yonekura; G A Richwald; S Greenland; R L Sweet; J Schachter
Journal:  JAMA       Date:  1990-06-20       Impact factor: 56.272

4.  Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group.

Authors:  M F Cotch; J G Pastorek; R P Nugent; S L Hillier; R S Gibbs; D H Martin; D A Eschenbach; R Edelman; J C Carey; J A Regan; M A Krohn; M A Klebanoff; A V Rao; G G Rhoads
Journal:  Sex Transm Dis       Date:  1997-07       Impact factor: 2.830

5.  Comparison of Aptima Trichomonas vaginalis transcription-mediated amplification assay and BD affirm VPIII for detection of T. vaginalis in symptomatic women: performance parameters and epidemiological implications.

Authors:  Sarah B Andrea; Kimberle C Chapin
Journal:  J Clin Microbiol       Date:  2011-01-19       Impact factor: 5.948

6.  Comparison of contraceptive use between the Contraceptive CHOICE Project and state and national data.

Authors:  Nupur D Kittur; Gina M Secura; Jeffrey F Peipert; Tessa Madden; Lawrence B Finer; Jenifer E Allsworth
Journal:  Contraception       Date:  2010-11-23       Impact factor: 3.375

7.  Studies relying on passive retrospective cohorts developed from health services data provide biased estimates of incidence of sexually transmitted infections.

Authors:  Charlotte K Kent; Janice K Chaw; Robert P Kohn; Ying Q Chen; Jeffrey D Klausner
Journal:  Sex Transm Dis       Date:  2004-10       Impact factor: 2.830

8.  Gonorrhea and chlamydia in the United States among persons 14 to 39 years of age, 1999 to 2002.

Authors:  S Deblina Datta; Maya Sternberg; Robert E Johnson; Stuart Berman; John R Papp; Geraldine McQuillan; Hillard Weinstock
Journal:  Ann Intern Med       Date:  2007-07-17       Impact factor: 25.391

9.  Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results.

Authors:  L Weström; R Joesoef; G Reynolds; A Hagdu; S E Thompson
Journal:  Sex Transm Dis       Date:  1992 Jul-Aug       Impact factor: 2.830

10.  Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection.

Authors:  D Scholes; A Stergachis; F E Heidrich; H Andrilla; K K Holmes; W E Stamm
Journal:  N Engl J Med       Date:  1996-05-23       Impact factor: 91.245

View more
  5 in total

1.  Trends and Progress in Reducing Teen Birth Rates and the Persisting Challenge of Eliminating Racial/Ethnic Disparities.

Authors:  Emmanuel M Ngui; Danielle M Greer; Farrin D Bridgewater; Trina C Salm Ward; Ron A Cisler
Journal:  J Racial Ethn Health Disparities       Date:  2016-07-20

2.  Risk-based screening for Chlamydia trachomatis and Neisseria gonorrhoeae prior to intrauterine device insertion.

Authors:  Jaclyn M Grentzer; Jeffrey F Peipert; Qiuhong Zhao; Colleen McNicholas; Gina M Secura; Tessa Madden
Journal:  Contraception       Date:  2015-06-17       Impact factor: 3.375

3.  The contraceptive CHOICE project round up: what we did and what we learned.

Authors:  Colleen McNicholas; Tessa Madden; Gina Secura; Jeffrey F Peipert
Journal:  Clin Obstet Gynecol       Date:  2014-12       Impact factor: 2.190

Review 4.  Trichomoniasis - are we giving the deserved attention to the most common non-viral sexually transmitted disease worldwide?

Authors:  Camila Braz Menezes; Amanda Piccoli Frasson; Tiana Tasca
Journal:  Microb Cell       Date:  2016-06-27

5.  Understanding of risk factors for the human papillomavirus (HPV) infection based on gender and race.

Authors:  Nosayaba Osazuwa-Peters; Eric Adjei Boakye; Rebecca L Rohde; Rajan N Ganesh; Ammar S Moiyadi; Adnan S Hussaini; Mark A Varvares
Journal:  Sci Rep       Date:  2019-01-22       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.